ROIV (Roivant Sciences) Days Inventory : 0.00 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Roivant Sciences Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Roivant Sciences's Average Total Inventories for the three months ended in Dec. 2024 was $0.0 Mil. Roivant Sciences's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.3 Mil. Hence, Roivant Sciences's Days Inventory for the three months ended in Dec. 2024 was 0.00.

The historical rank and industry rank for Roivant Sciences's Days Inventory or its related term are showing as below:

ROIV' s Days Inventory Range Over the Past 10 Years
Min: 76.76 Med: 261.3 Max: 445.83
Current: 388.91

During the past 4 years, Roivant Sciences's highest Days Inventory was 445.83. The lowest was 76.76. And the median was 261.30.

ROIV's Days Inventory is ranked worse than
76.95% of 642 companies
in the Biotechnology industry
Industry Median: 181.485 vs ROIV: 388.91

Roivant Sciences's Days Inventory declined from Dec. 2023 (2,349.57) to Dec. 2024 (0.00).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Roivant Sciences's Inventory-to-Revenue for the three months ended in Dec. 2024 was 0.00.

Roivant Sciences Days Inventory Historical Data

The historical data trend for Roivant Sciences's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Days Inventory Chart

Roivant Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Days Inventory

76.76

445.83

Roivant Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Inventory	Get a 7-Day Free Trial														2,349.57	130.49	794.23	13,257.38	-

Competitive Comparison of Roivant Sciences's Days Inventory

For the Biotechnology subindustry, Roivant Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roivant Sciences's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roivant Sciences's Days Inventory distribution charts can be found below:

* The bar in red indicates where Roivant Sciences's Days Inventory falls into.

Save Embed

;

Save Embed

;

Roivant Sciences Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Roivant Sciences's Days Inventory for the fiscal year that ended in Mar. 2024 is calculated as

	Days Inventory (A: Mar. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Mar. 2023 )	+	Total Inventories (A: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2024 )	*	Days in Period
=	( (2.761	+	35.251)	/	2 )	/	15.56	*	365
=	19.006					/	15.56	*	365
=	445.83

Roivant Sciences's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:

	Days Inventory (Q: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2024 )	+	Total Inventories (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0.259	*	365 / 4
=	0					/	0.259	*	365 / 4
=	0.00

Roivant Sciences (NAS:ROIV) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Roivant Sciences's Inventory Turnover for the three months ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.259	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Roivant Sciences's Inventory to Revenue for the three months ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	9.018
	=	0.00

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Roivant Sciences Days Inventory Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Roivant Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (NAS:ROIV) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

87S:Germany

Address

50 Broadway, 7th Floor, London, GBR, SW1H 0BD

Website

https://www.roivant.com

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Executives

Eric Venker	officer: President & COO	C/O ROIVANT SCIENCES, INC., 320 WEST 37TH STREET, 6TH FLOOR, NEW YORK NY 10018
Rakhi Kumar	officer: Chief Accounting Officer	C/O NEUROPACE INC, 455 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Mayukh Sukhatme	officer: See Remarks	C/O UOVANT SCIENCES, INC., 5151 CALIFORNIA AVENUE, SUITE 250, IRVINE CA 92617
Daniel Allen Gold	director	6720 VIA AUSTI PARKWAY, SUITE 450, LAS VEGAS NV 89119
Qvt Financial Lp	10 percent owner, other: Director by Deputization	888 SEVENTH AVENUE, 43RD FLOOR, NEW YORK NY 10106
Keith S Manchester	director	C/O ROIVANT SCIENCES LTD., 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FL, LONDON X0 SW1Y 4L
Matthew Gline	director, officer: CEO	C/O UROVANT SCIENCES, INC., 5151 CALIFORNIA AVENUE, SUITE 250, IRVINE CA 92617
Svf Investments (uk) Ltd	10 percent owner	69 GROSVENOR STREET, LONDON X0 W1K3JP
Viking Global Investors Lp	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Viking Global Performance Llc	10 percent owner	55 RAILROAD AVENUE, 3RD FLOOR, GREENWICH CT 06830
Sumitomo Chemical Co., Ltd.	10 percent owner	7-1, NIHONBASHI 2-CHOME, CHUO-KU, TOKYO M0 103-6020
Viking Global Opportunities Parent Gp Llc	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Softbank Vision Fund L.p.	10 percent owner	AZTEC GROUP HOUSE, 11-15 SEATON PLACE, ST HELIER Y9 JE4 0QH
Meghan Fitzgerald	director	C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Richard Pulik	officer: CFO	SUITE 1, 3RD FLOOR, 11-12 ST. JAMES'S SQUARE, LONDON X0 SW1Y 4LB